Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
Tue, 07th Oct 2014 18:12
(Sharecast News) - New high-level results from AstraZeneca's TROPION-Breast01 phase three trial, released on Friday, carried encouraging news for patients with inoperable or metastatic hormone receptor (HR)-positive, HER2-low or negative breast cancer.
Read more
(Alliance News) - AstraZeneca PLC on Wednesday said rare disease business Alexion has signed a purchase and licence agreement for a rare disease programme portfolio from Pfizer Inc.
Read more(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd's Enhertu has been recommended for approval in the EU on Friday.
Read more(Alliance News) - Smith & Nephew PLC on Thursday announced that BT Group PLC's chief financial officer, Simon Lowth, will join the board as independent non-executive director on January 1.
Read more(Alliance News) - AstraZeneca PLC on Monday said that its therapy, Fasenra, met the primary endpoint in the Mandara phase three trial in eosinophilic granulomatosis with polyangiitis.
Read more(Alliance News) - AstraZeneca PLC reported positive clinical results of combinations of its Imfinzi and Tagrisso drugs with other treatments for lung cancer, while also seeing "strong and durable" tumour responses from its Enhertu antibody drug conjugate.
Read more(Alliance News) - Stocks in London are called higher on Monday, ahead of a busy week of interest rate decisions and economic data.
Read more(Alliance News) - AstraZeneca PLC reported positive clinical results of combinations of its Imfinzi and Tagrisso drugs with other treatments for cancer.
Read more(Alliance News) - AstraZeneca PLC on Wednesday said it is working closely with the US Food & Drug Administration regarding a request to changes to improve risk evaluation for Ultomiris.
Read more(Sharecast News) - Pharma giant AstraZeneca said it is "working closely" with US regulators to clarify some details of its Ultomiris drug as it hopes to bring the treatment to market as quickly as possible for people suffering from the rare disease, neuromyelitis optica spectrum disorder (NMOSD).
Read more| Tuesday 5 September | |
| no events scheduled | |
| Wednesday 6 September | |
| no events scheduled | |
| Thursday 7 September | |
| Admiral Group PLC | ex-dividend payment date |
| Alpha Financial Markets Consulting PLC | ex-dividend payment date |
| Anglo-Eastern Plantations PLC | ex-dividend payment date |
| Assura PLC | ex-dividend payment date |
| Athelney Trust PLC | ex-dividend payment date |
| Baltic Classifieds Group PLC | ex-dividend payment date |
| Blackrock World Mining Trust PLC | ex-dividend payment date |
| CLS Holdings PLC | ex-dividend payment date |
| CT UK Capital & Income Investment Trust PLC | ex-dividend payment date |
| Derwent London PLC | ex-dividend payment date |
| Develop North PLC | ex-dividend payment date |
| DS Smith PLC | ex-dividend payment date |
| Empiric Student Property PLC | ex-dividend payment date |
| GlobalData PLC | ex-dividend payment date |
| Greggs PLC | ex-dividend payment date |
| Harbour Energy PLC | ex-dividend payment date |
| Pollen Street PLC | ex-dividend payment date |
| Prudential PLC | ex-dividend payment date |
| Relx PLC | dividend payment date |
| RM Infrastructure Income PLC | ex-dividend payment date |
| Serco Group PLC | ex-dividend payment date |
| Severfield PLC | ex-dividend payment date |
| VPC Specialty Lending Investments PLC | ex-dividend payment date |
| XP Power Ltd | ex-dividend payment date |
| Zotefoams PLC | ex-dividend payment date |
| Friday 8 September | |
| abrdn New Dawn Investment Trust PLC | dividend payment date |
| Avon Protection PLC | dividend payment date |
| Berkeley Group Holdings PLC | dividend payment date |
| Chemring Group PLC | dividend payment date |
| Ecofin US Renewables Infrastructure Trust PLC | dividend payment date |
| iomart Group PLC | dividend payment date |
| Keller Group PLC | dividend payment date |
| Lookers PLC | dividend payment date |
| Moneysupermarket.com Group PLC | dividend payment date |
| Nichols PLC | dividend payment date |
| Tritax EuroBox PLC | dividend payment date |
| Tyman PLC | dividend payment date |
| Monday 11 September | |
| AstraZeneca PLC | dividend payment date |
| Games Workshop Group PLC | dividend payment date |
| Rentokil Initial PLC | dividend payment date |
| Residential Secure Income PLC | dividend payment date |
| ThomasLloyd Energy Impact Trust PLC | dividend payment date |
| Copyright 2023 Alliance News Ltd. All Rights Reserved. | |
(Alliance News) - Stock prices in London were higher at midday on Monday, with market mood buoyed by news of stimulus measures in China and increasing optimism for the future of interest rates across the Atlantic.
Read moreAstraZeneca PLC - Cambridge-based pharmaceutical maker - Astra's Calquence is approved in China for treatment of chronic lymphocytic leukaemia or small lymphocytic lymphoma in adult patients who have received at least one prior therapy. The National Medical Products Administration approves Calquence, whose generic name is acalabrutinib, based on two different trials, including one in China. Astra notes that CLL is the most prevalent type of adult leukaemia around the world and represents about 6.4% of B-cell non-Hodgkin lymphoma patients in China. Calquence already is approved for treatment of CLL and SLL in the US and Japan and is approved for CLL in the EU.
Read more(Alliance News) - Stocks in London are expected to open on a positive note on Monday, amid an improvement in global risk sentiment.
Read more
Aug 29(Reuters) - The Biden administration on Tuesday released its list of 10 prescription medicines that will be subject to the first-ever price negotiations by the U.S. Medicare health program that covers 66 million people, with big-selling blood thinner Eliquis from Bristol Myers Squibb and Pfizer among them.
Read more
Last checked at